Pharma

Your Article Summary

See Latest Articles

Mylans Matrix Receives First Tentative FDA Approval Under PEPFAR for Generic Truvada
Mylan, 03/31/09

Mylan Inc. announced that Matrix Laboratories Limited, its India-based subsidiary in which it holds a 71.2% controlling interest, has received the first tentative approval from the U.S. Food and Drug Administration under the President's Emergency Plan for AIDS Relief for its Abbreviated New Drug Application for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 200 mg/300 mg.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

Cell Therapeutics Announces FDAs Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkins Lymphoma, February 2010
Cell Therapeutics, 12/18/09

Eslicarbazepine: A novel antiepileptic agent designed for improved efficacy and safety
Formulary , 12/16/09

Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/16/09

 See all of Drug/Product Approvals